Peter Smith

ORCID: 0000-0002-2051-7774

Also affiliated with Public Health Ontario, United Therapeutics (United States), Institute for Work & Health

MedicineArts and Humanities

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes”.

Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes

CHEST Journal(2022)10.1016/j.chest.2022.09.007

N/A

1.1DataRank · unranked

43 citations

C. Q. Deng, Christopher S. King, Hilary M. DuBrock, Jean Elwing, Sudarshan Rajagopal +8 more

Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study

European Respiratory Journal(2023)10.1183/13993003.02414-2022

N/A

0DataRank · unranked

69 citations

Ricardo Restrepo‐Jaramillo, Thenappan Thenappan, Peter A. Engel, ABUBAKR A BAJWA, Ashwin Ravichandran +9 more